Nonsteroidal AntiInflammatory Drugs (NSAIDs)
Market
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Market Size and Growth
The Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market research reports indicate a growing demand for NSAIDs due to the rising prevalence of chronic inflammatory diseases. The market size is estimated to be worth $14.7 billion in 2021 and is projected to reach $19.5 billion by 2026, with a CAGR of 5.8%. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Novartis
◍ Pfizer
◍ Boehringer Ingelheim
◍ Teva Pharmaceutical
◍ Hospira
◍ Lonza Group
◍ Mylan
◍ Aurobindo Pharma
◍ Dr. Reddy's Laboratories
◍ Actavis
◍ Wuxi Apptec
◍ Zhejiang NHU
The Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market is highly competitive with key players like Novartis, Pfizer, Boehringer Ingelheim, Teva Pharmaceutical, Hospira, Lonza Group, Mylan, Aurobindo Pharma, Dr. Reddy's Laboratories, Actavis, Wuxi Apptec, Zhejiang NHU dominating the market. These companies contribute significantly to the growth of the NSAIDs market by developing innovative products and expanding their global presence.
- Novartis: $48.65 billion in sales revenue
- Pfizer: $52.82 billion in sales revenue
- Teva Pharmaceutical: $17.4 billion in sales revenue
Request Sample Report
Market Segmentation
By Application
◍ Hospital Pharmacies
◍ Retail Pharmacies
◍ Online Pharmacies
Request Sample Report
By Product
Paracetamol
Ibuprofen
Aspirin
Naproxen
Others
◍
◍
◍
◍
◍
Market Growth
Request Sample Report
$ X Billion USD
THANK YOU Email : sales@reportprime.com USA : +1 507 500 7209 Website : https://www.reportprime.com/ Request Sample Report Contact US Our Clients